It has been a busy year for patent cases at the U.S. Supreme Court. The court recently issued its opinion in Halo and Stryker cases (regarding enhanced damages) and is preparing an opinion for the Cuozzo case (regarding the broadest reasonable interpretation claim construction standard use in IPR proceedings). That said, a number petitioners are asking the Supreme Court to review additional decisions involving patent issues. In this two-part article, we review some of the key pending petitions that may impact the life sciences industry, and comment on the likely outcome of each petition.
Download the full versions of this two-part Law360 article below: